| Page 916 | Kisaco Research
 

Matthew Hulse

Associate General Counsel
Intel Corporation

Matthew Hulse

Associate General Counsel
Intel Corporation

Matthew Hulse

Associate General Counsel
Intel Corporation
 

Jeff Pade

Partner
Paul Hastings LLP

Jeff Pade

Partner
Paul Hastings LLP

Jeff Pade

Partner
Paul Hastings LLP
 

Matt Murphy

Partner
Axinn Veltrop & Harkrider LLP

Matt Murphy

Partner
Axinn Veltrop & Harkrider LLP

Matt Murphy

Partner
Axinn Veltrop & Harkrider LLP
2022 Agenda
Interview: Alexander Schinagl, Co-Founder & CTO, OncoOne
 

Florian Lachenmeier

Head of Compliance
Crypto Finance AG

Education:

M.A. HSG in Accounting and Finance. Swiss Certified Public Accountant. Licensed Audit Expert. Lead Auditor for Banks and Securities Dealer

 

Experience:

Florian Lachenmeier

Head of Compliance
Crypto Finance AG

Florian Lachenmeier

Head of Compliance
Crypto Finance AG

Education:

M.A. HSG in Accounting and Finance. Swiss Certified Public Accountant. Licensed Audit Expert. Lead Auditor for Banks and Securities Dealer

 

Experience:

Since January 2023: Crypto Finance Group: Head of Compliance. 2018-2022: Geissbühler Weber & Partner (gwp) Focus: licensing, risk management, compliance, investigations. 2017: Swiss Financial Market Supervisory Authority Secondment Supervisory team large banks (Focus: compliance, conduct, COO). 2007-2018: Deloitte AG Assurance and Advisory Financial Services Industry. 2005: UBS Accounting & Reporting in the Wealth Management & Business Banking division

Francesca Hodges

   I am delighted to be involved with AMR Connect as I believe it's a well thought out event that aims to deliver the key message that AMR is a multifactorial issue that needs immediate attention. In particular, I liked the        inclusion of a showcase for innovative companies developing antimicrobial products in the AMR space and the show of support for drug development in this area. I also appreciated the inclusion of non-traditional antimicrobial approaches and the holistic attitude in including a policy focussed session.   

Francesca Hodges

I am delighted to be involved with AMR Connect as I believe it's a well thought out event that aims to deliver the key message that AMR is a multifactorial issue that needs immediate attention. In particular, I liked the inclusion of a showcase for innovative companies developing antimicrobial products in the AMR space and the show of support for drug development in this area. I also appreciated the inclusion of non-traditional antimicrobial approaches and the holistic attitude in including a policy focussed session. 

Francesca Hodges

I am delighted to be involved with AMR Connect as I believe it's a well thought out event that aims to deliver the key message that AMR is a multifactorial issue that needs immediate attention. In particular, I liked the inclusion of a showcase for innovative companies developing antimicrobial products in the AMR space and the show of support for drug development in this area. I also appreciated the inclusion of non-traditional antimicrobial approaches and the holistic attitude in including a policy focussed session.